Facebook Instagram Linkedin Twitter Youtube
  • Home
  • Equities By Sectors
    • Basic Materials
    • Communication Services
    • Consumer Cyclical
    • Consumer Defensive
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Utilities
  • Thematics
  • Interviews
  • About Avise Equities
    • Career
  • Equity Research
  • Contact us
Search

LogoAvise AnalyticsWe value your company

  • About Avise
  • Meet Us
  • Events
  • Login / Subscribe
  • Home
  • Equities
  • Thematics
  • Interviews

  • About Avise Equities
  • Equity Research
  • Contact us

EQUITIES

EQUITIES BY SECTOR

Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities

THEMATICS

LATEST

Content coming soon.

INTERVIEWS

LATEST

Videos
08 . 13 . 2019
The Future of Hepatitis-B Treatment [ MUST WATCH ]
Videos
08 . 13 . 2019
A Future without Chronic Pain [MUST WATCH]
Videos
08 . 13 . 2019
Rising Problems & Innovations in the Treatment of Stroke – [Health Matters]

ABOUT AVISE EQUITIES

  • About Avise Equities
  • Career
“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”
Financial Director

LogoAvise AnalyticsWe value your company

Exclusive Content:

The Future of Hepatitis-B Treatment [ MUST WATCH ]

November 8, 2024 0

A Future without Chronic Pain [MUST WATCH]

August 13, 2019 0

Rising Problems & Innovations in the Treatment of Stroke – [Health Matters]

August 13, 2019 0

Biotechnology

A paradigm shift in the ACNE treatment industry?

Avise Analytics - March 22, 2019 0
Biotechnology

Harnessing the power of Immunity to Combat Cancer          

Avise Analytics - March 22, 2019 0
Biotechnology

New treatment approaches in the SUI market aim to plug the...

Avise Analytics - March 22, 2019 0
Biotechnology

Emerging Therapeutics for Dry Eye Syndrome seek to hit the bull’s...

Avise Analytics - March 16, 2019 0
Biotechnology

Rising Problems & Innovations in the Treatment of Stroke – [Health...

Avise Analytics - March 5, 2019 0
Biotechnology

New therapeutics promise respite to patients suffering from COPD

Avise Analytics - February 27, 2019 5
Biotechnology

Can These Breakthrough Therapeutics win the fight against Mesothelioma?

Avise Analytics - February 26, 2019 0
Biotechnology

Artificial Intelligence Spearheading the Fight against Cancer

Avise Analytics - February 23, 2019 0
Biotechnology

Timely Diagnosis and Precise Action – The Need of the Hour...

Avise Analytics - February 19, 2019 1
Biotechnology

Companies Pioneering Novel Solutions to Tackle Obesity

Avise Analytics - February 19, 2019 0
1...5678Page 6 of 8

Recent Comments

  • Marina Torres on 5 Promising Stocks In The Stroke Management Industry
  • Finlay Cedar on New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis
  • Tshepo Prence on New therapeutics promise respite to patients suffering from COPD
  • Finlay Cedar on Is a cure for Alopecia Areata on the horizon? New research shows promise
  • Anton on THE FUTURE OF HEPATITIS-B TREATMENT [ MUST WATCH ]

EDITOR PICKS

Parcel Pal Technologies – On the Quick Road to Success

June 26, 2019

Gene Therapy offers Cure for Bubble Boy Syndrome

June 20, 2019

Curaleaf Holding: Forging the largest acquisition in U.S cannabis landscape

May 6, 2019

POPULAR POSTS

New therapeutics promise respite to patients suffering from COPD

February 27, 2019

New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis

February 13, 2019

Is a cure for Alopecia Areata on the horizon? New research...

March 22, 2019

POPULAR CATEGORY

  • Biotechnology61
  • Clinical Trials59
  • FDA58
  • Trending57
  • IND52
  • Results48
  • Industry44
  • NDA37
  • Menu Client20
ABOUT US
Founded in 2012, Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lack adequate coverage. Avise is an approved research contributor on premier investor platforms such as Thomson Reuters, Factset and CaptialIQ.
Contact us: info@aviseanalytics.com
FOLLOW US
Facebook Instagram Linkedin Twitter Youtube
  • Disclaimer
  • Privacy
  • Contact Us
© Copyright 2019 aviseanalytics.com | All Rights Reserved.

REQUEST FREE COVERAGE

We also publish independent equity research reports, articles and interview videos on micro cap and small cap companies based on our initial research and investors interest.

We encourage OTC or NASDAQ based PUBCOS to reach out for a free coverage report.

EMAIL US

GET ON THE LIST

Join our mailing list for latest coverage reports and articles, and our special coverage videos of daily market analysis on small cap companies - "Lastday Movers"

    WORK WITH US

    We are looking for talented interns to learn and help investors find valuable companies.

    APPLY